chrisvoncsefalvay/vaers-outcomes huggingface dataset:
I woke up in the middle of the night 23 days after my second dose of the Pfizer covid vaccine with intense chest pain like I have never felt before. Nothing I did would lessen it (moving, ice, drinking water, etc). Eventually, I went back to sleep until I went to urgent care the next day where they said costochondritis and prescribed rest and ibuprofen. This did not help at all and the pain was consistently there for the next week. Then the tingles started. I first felt it in the back of my arms, then my legs, soon my face, and then all over my chest. My thumbs went numb intermittently. These symptoms appeared seemingly at random throughout my day for weeks at varying levels of intensity. They could come suddenly and then persist from anywhere from 20 minutes to hours. Then they would fade and a different part of my body begin to tingle. All while having a now dull chest pain constantly. Several times I would wake up in the middle of the night tingling all over and would not be able to go back to sleep - it was terrifying to feel like your body is attacking itself. Over the course of several months, I had extensive blood work done, an EKG heart stress test, and an MRI of my brain and spine along with numerous phone and in-person appointments with multiple general practitioners, specialists, physical therapists, and a psychologist.  ALL of them said everything looked fine and on paper, I am perfectly healthy with no explanation for my symptoms. Eventually, after months, the symptoms began to fade. The tingling left first and then the chest pain - although I do occasionally still feel it but much less intense. It is like waves come and go with each wave lasting less time and being less intense. I can only hope that eventually it will go away and I will not feel like this anymore. I have no underlying health conditions and am a healthy 34-year-old woman at a healthy weight.
Initial report received from a nurse on 22 Dec 2009: This pregnant patient was vaccinated first time with S-OIV FLUVIRIN (batch no: 1008131P) on 21 Oct 2009. A second dose of FLUVIRIN was administered on 02 Nov 2009. No adverse event was reported.
Information has been received from a consumer concerning her 2 year old son who was vaccinated with a 1st, 2nd and 3rd dose of Hep-B vaccine recombinant (yeast) on 10/30/98, 11/30/98 and 8/3/99, respectively. In approx. 3/01, the pt began exhibiting strange play behaviors as compared to other children. On 9/26/01, he was dx'd with "PPD". Upon internal medical review, the pt's PPD was considered to be an "Other Important Medical Event". Additional information has been requested. Follow-up info from the physician indicated that she "did not think that there was any relationship to the hepatitis B vaccine recombinant vaccine and the pt's diagnosis." Additional info has been requested.
This spontaneous report as received from a registered nurse refers to an unspecified number of patients of unknown age and gender. On an unknown dates, the patients were vaccinated with PROQUAD (Merck) (dose, route, lot# and expiration date were not reported) that were exposed to unsupported temperature conditions. No adverse experience had been observed or reported by any of the patients who received these improperly-stored doses. No PQC (product quality complaint) was involved. This is one of several reports received from the same reporter. Additional information has been requested.
No adverse event; Administered a dose of the Moderna Covid-19 vaccine that had expired on 28NOV2022; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Administered a dose of the Moderna Covid-19 vaccine that had expired on 28NOV2022) and NO ADVERSE EVENT (No adverse event) in a 50-year-old female patient who received mRNA-1273 (Spikevax) (batch no. 083B22A) for COVID-19 vaccination.     Concurrent medical conditions included Bipolar disorder. Concomitant products included CARBAMAZEPINE, COLECALCIFEROL (VITAMIN D3) and PHENYTOIN SODIUM for an unknown indication.    On 02-Dec-2022, the patient received first dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On 02-Dec-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Administered a dose of the Moderna Covid-19 vaccine that had expired on 28NOV2022). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Administered a dose of the Moderna Covid-19 vaccine that had expired on 28NOV2022) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 (Spikevax) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (Administered a dose of the Moderna Covid-19 vaccine that had expired on 28NOV2022).    It was reported that no other adverse reactions reported. Individual vial was used and vail size was 5.5ml. Vial thawed straight out of the freezer. The vial did not undergo any temperature excursions. No treatment medication details was reported.
About 8-9 hours after receiving the 2nd in series, she awoke at about 01:30 AM with pain in R arm (where injected) from wrist to shoulder. She also experienced about 10 minutes of shaking with no L.O.C. Resolved and no further symptoms. (No problems 24 hours after 3rd.
Second dose administered an adult dose from an adult Pfizer preparation, and patient only 11.5 y/o. Patient tolerated well dose upon phone follow up.
Very sore arm hurts when moved. Nurse gave both shots in right arm still very sore 7 weeks later.
Patient presented to office for apt and provider ordered Flu vaccine for pt and children of pt. I checked lot numbers and expiration date of all vaccines and labeled all caps with vaccine and pt name. Tdap and Flu are stored next to each other and both green in color. Even with double checking label it was missed that the Tdap was given until after vaccine was given to pt instead of flu. The clinic manager and pt were both notified as soon as I realized the mistake was made. The patient was not upset and understanding to the error.
This spontaneous report was received from a female patient of unknown age who is also a company representative, referring to herself. The patient's pertinent medical history, drug reactions/allergies, concurrent conditions and concomitant medications were not reported. On an unknown date, when the patient was 26 year old, she was vaccinated with the first dose GARDASIL 9 for prophylaxis (route of administration, anatomical location, lot # and expiration date were not reported). On another unreported date, when the patient was 26 year old, she was vaccinated with the second dose GARDASIL 9 for prophylaxis (route of administration, anatomical location, lot # and expiration date were not reported). No adverse effects were reported.
have had a tinnitus ever since; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non-HCP), Program ID:. The reporter is the patient.  A 61-year-old patient received BNT162b2 (BNT162B2), in Dec2021 as dose 3 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient had no relevant medical history. The patient's concomitant medications were not reported. Vaccination history included: Covid-19 vaccine (DOSE 1; MANUFACTURER UNKNOWN), for COVID-19 immunization; Covid-19 vaccine (DOSE 2; MANUFACTURER UNKNOWN), for COVID-19 immunization. The following information was reported: TINNITUS (non-serious), outcome "unknown", described as "have had a tinnitus ever since".  Additional Information: Subject: Patient Assistance. Customer Verbatim: I received the third Pfizer vaccine in Dec2021 and have had a tinnitus ever since, I am a healthy 61-year-old and do not have any health issues. I will not be getting another COVID vaccine due to this. Forwarded as an Adverse Event by the regulatory authority on 07Apr2022. Reporter provided verification of contact address on 06Apr2022.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
started with pain at the injection site on my left deltoid I also felt a little lightheaded and dizzy for a little while than I started having pain in my arm and turned to numbness and tingling
LVN staff administered covid-19 vaccine on 10/12/21 at 1445 not knowing that pt already had J&J covid-19 vaccine on 3/12/21. Pt reported to the staff that he had received his first J&J covid-19 vaccine after the vaccine was administered by the staff. Pt was monitored by the staff and left the covid-19 vaccine clinic in a stable condition.
my menstrual cycle is lasting 7-12 compared to 4 days prior to the vaccine. And I'm bleeding alot heavier than normal.
swelling of the lymph nodes in armpits; This is a spontaneous report received from a non-contactable reporter (Consumer or other non HCP). The reporter is the patient.  A female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection) (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: LYMPHADENOPATHY (non-serious), outcome "unknown", described as "swelling of the lymph nodes in armpits".  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Headache, Myalgia, Arthralgia, NauseaVomiting,  sore throat and runny nose
When I woke up I noticed that area around injection site was swollen, red, itchy, and radiating heat. Size is about 2 inches circumference around.
A patient received her first dose of GARDASIL 9 three years ago, received a second dose on 5/29/2019, and was currently in the office to receive the third dose of the series.; no adverse effects; This spontaneous report was received from a nurse concerning a female patient of unknown age. No information was provided regarding the patient's medical history, concurrent conditions, concomitant medications or drug reactions/allergies. On an unspecified date in 2016, also reported as about three years ago, the patient received the first dose of hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) for prophylaxis (dose, route of administration, lot number and expiration date were not reported). On 25-MAY-2019, the patient was administered a second dose of hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) for prophylaxis (dose, route of administration, lot number and expiration date were not reported) (inappropriate schedule of product administration). The patient was currently in the office to receive the third dose of the series. No adverse effects reported.  The outcome of inappropriate schedule of product administration was not reported.
sick; Initial information was received on 15-Oct-2020 regarding an unsolicited valid non-serious case from a consumer/non-healthcare professional via social media.  This case involves an patient (demographics unknown) who was sick (illness), when received INFLUENZA VACCINE.  The patient had no medical history, concomitant disease or risk factor  Medical treatment(s), vaccination(s), concomitant medications and family history were not provided.   On an unknown date, the patient received a dose of suspect INFLUENZA VACCINE produced by unknown manufacturer (lot number: not reported; expiry date not reported) via unknown route in unknown administration site for prophylactic vaccination.  On an unknown date, the patient was sick (illness) (unknown latency) following the administration of INFLUENZA VACCINE. It  was weird how the patient always got sick with it.  It is unknown if the patient experienced any additional symptoms/events  There were no lab data/results available  It was not reported if the patient received a corrective treatment.  At, the time of report the outcome of the event was unknown.  There will be no information available on the batch number for this case.
Information has been received from a physician concerning a 72-year-old male with hypertension, gout, pain, gastrooesophageal reflux disease and no know allergies or drug reactions who on 01-APR-2008 was vaccinated subcutaneous with 0.65 mL dose of zoster vaccine live (Oka/Merck) (lot # 659760/0159X). Concomitant therapy included LOTREL, allopurinol, gabapentin, LIPITOR and PROTONIX. On 09-MAY-2008, the patient experienced a diffuse "classic" vesicular rash on his torso, arms and legs that was described as a " dew drop on a rose bare" vesicular rash. The rash was pruritic and identified by the physician as varicella. The patient was treated VALTREX 500 mg orally three times a day for 7 days and FAMVIR. No diagnostic labs were performed. At the time of the report the patient's status was recovering. A product quality complaint was not involved. Additional information has been requested.
vial first expired then stored in refrigerator on same date of administration; Vaccine was expired on 04-Apr-2022 and administered on 16-Apr-2022; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Vaccine was expired on 04-Apr-2022 and administered on 16-Apr-2022) and PRODUCT STORAGE ERROR (vial first expired then stored in refrigerator on same date of administration) in a 63-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 066H21A) for COVID-19 vaccination.     No Medical History information was reported.    On 16-Apr-2022, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 16-Apr-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Vaccine was expired on 04-Apr-2022 and administered on 16-Apr-2022). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (vial first expired then stored in refrigerator on same date of administration). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Vaccine was expired on 04-Apr-2022 and administered on 16-Apr-2022) and PRODUCT STORAGE ERROR (vial first expired then stored in refrigerator on same date of administration) outcome was unknown. Not provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Patient weight was reported as 240. Concomitant medications were not reported. The patient had received 2nd booster dose. Patient had reported no adverse events. 28 patients might had received the expired Moderna COVID-19 vaccine. The vials were thawed the same day of administration. The vials did not undergo any temperature excursions. Treatment information was not reported.
Dehydration; perceived fever. I actually did not have any fever when I checked.; I am toughing it out but it was so uncomfortable; This is a spontaneous report from a contactable consumer (patient himself). A 37-year-old male patient received the first dose of  BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration, administered in arm left on 11Mar2021 08:30 am (at age of 37-year-old) (Lot Number: EN6203) at single dose  for COVID-19 immunisation. Medical history included obesity and allergic to Penicillin. The patient was diagnosed with COVID-19 prior to vaccination. There were no concomitant medications. The patient experienced dehydration and perceived fever.The patient  actually did not have any fever when he checked. The patient reported 'I am toughing it out but it was so uncomfortable I wanted to make sure I reported it. I feel near where I did my worse days of COVID when I was on oxygen'.  The events start date was 12Mar2021 02:00 am.  The events were reported as non-serious. No treatment received for the events. Since the vaccination, the patient has not  been tested for COVID-19. The outcome of the events was not resolved.          .
Shot given 7APR92; 9APR92 mom c/o vax rxn; no lump felt, no erythema, no limit ROM, color good, moves all ext WNL, vascular WNL; tx warm, moist heat, APAP & f/u in office;
patient had what was described as "the virus" (implying the corona virus); patient had what was described as "the virus" (implying the corona virus); This is a spontaneous report from a contactable consumer via a Pfizer colleague.  An adult male patient received bnt162b2 (BNT162B2), dose 2 via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as DOSE 2, SINGLE; dose 1 via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as DOSE 1, SINGLE for COVID-19 immunisation. The patient medical history and concomitant medications were not reported. It was reported that the patient had what was described as "the virus" (implying the corona virus) and was recovering. At the time of the report, the patient was still congested from the disease. Outcome of the events was recovering.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected
PT COMPLAINS OF CONTINUED PAIN AT SITE OF INJECTION GOING ON FOR APPROX. 2 MONTHS.  STATES INJECTION WAS GIVEN IN HIGH DELTOID AREA. ADVISED PT TO TRY OTC ADVIL FOR 3-4 DAYS AND IF NO IMPROVEMENT TO SEE HER PCP.
local soreness at injection site, days 1 - 3.  On day 7 (almost exactly) started to have red, warm, itchy bump over injection side deltoid, size of half dollar.  Took Zyrtec / Singulair, went to bed. In AM (8h) larger size (2.5 x 3") with warmth, redness, less swelling, increased itching.  Applied triamcinolone.  Situation still evolving.
0755 Student presented pale c/o nausea since last night. Student states she feels if she eats anything she will vomit. Student allowed to rest x 30min without relief. Parent notified student dismissed to home 0900.
This is a 76 year old female,  with past medical history signficant for Hypertension, Hyperlipidemia, Paroxysmal Atrial Fibrillation, Osteoarthritis, who presented to the ED s/p mechanical fall 2/2 Dizziness. The patient tested positive for Covid 19 on 12/4, and was initially set up to have a BAM infusion. She sustained a fall and subsequent right hip pain last night therefor presented to the ED today for further work up and evaluation. A CXR showed bilateral infiltrates, left greater than right. Her CPK was >4,000. A CT of the head showed no acute abnormality
MANUFACTURE EXPIRATION DATE OF 9/30/22. INFORMATION RECEIVED FROM MANUFACTURE INDICATING THAT STABILITY DATA SUPPORTS THE USE OF THIS PRODUCT THROUGH OCT 19
Myalgia, NauseaVomiting, pain and swelling at injection site Narrative: Per nursing report: "called [9/2] with complains of adverse symptoms after receiving her 2nd dose of Moderna vaccine on 9/1/2021. Employee complains of body aches, nausea and vomiting, and injection site pain and swelling. "
no adverse event, moderna confirmed 216k22A was  viable until 2/21/23 despite beyond use date of 1/22/23
Red, itchy, swollen arm x 10 days at the injection site -about the size of a softball ( Arm very sensitive to touch and clothes on it).  After 10 days, arm was no longer swollen but still itchy and red (decreased to the size of a baseball).
Feeling of electrical jolt, tinlgy, numb, pins and needles across different body parts (arms, hands, back, thighs, feet, face, scalp).  The feeling spreads in the particular area and last from 5 seconds to 20 seconds. The feeling is very uncomfortable  and at times painful.
This spontaneous case was reported by an other and describes the occurrence of   in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) at an unspecified dose. No concomitant mediation was reported. No treatment medication was reported. Reporter did not allow further contact.
Pt given expired dose of PCV Lot #G98915 Exp. 01/01/2015.
23 hours after injection - chills, fever 100.4, nasal stuffiness, tiredness, general unwell feeling, sore arm at injection site, diarrhea  These symptoms lasted about 10-11 hours, then were gone      (took 2 extra strength tylenol at start of fever)  Only with 2nd dose.   1st dose was fine
11Mar87 pt vax;  30Aug90 devel serologically confirmed measles & hospitalized.
Increased weakness, confusion.  All occured after surgery but was doing well postoperatively until 2nd dose given 2/4/2021  Then became confused, weak and unable to care for self.
8 hrs after vaccine had fever if 104 and pulse of 125. Very weak and dizzy. This continued until the next morning.Took 1300 MG acetaminophen.  Had no effect. Used ice bags, had no effect.
Fever, difficulty breathing, chills, nausea Eat 2 pieces of Tyleno
Severe pain on the side of body in which the vaccine was administered, starting in the arm/bicep and shooting down to the leg. Sweating, chills, presumed fever starting 4 hours after vaccine administration. Unable to leave bed due to pain/discomfort, incontinent while in bed. Stayed in bed until the morning, noticed symptoms improve upon waking and are continuing to improve
Patient called the pharmacy the day after receiving the vaccination at one of our outside vaccination events. He reported redness and warmth on the arm of the vaccination.
Within the first few minutes I became fuzzy and within 15 minutes I began having a rapid heartbeat and palpitations.  Those effects have continued for the last month.  My doctor has diagnosed me with PVC as a result of the vaccination and advised that I do not receive the 2nd shot.  Since I am uninsured my doctor made a house call on his own personal time so as to not acrue a large bill.  He suggested that I continue to be aware of my symptoms and how they are impacting my life and go to the emergency room if I begin having  more serious episodes.
Patient received vaccine on 9/17/2004; developed red papules and vesicles on 10/1/04; afebrile. Seen in office on 10/2/04-T100.1(ax), vesicles (few) and papules over trunck, arms, legs (few). Dx made of varicella vaccine reaction. General support for fever. Home quarantine.
Patient reports that about an hour after the vaccine was given she developed headache, fatigue and cough. The next day she continued to feel poorly and was seen by myself in our walk in clinic.  In addition she had dizziness, felt cold, had increased thirst, had hoarseness, and felt like her legs were heavy. No rashes.  I treated her with epinephrine and her respiratory symptoms improved.  She was sent home after being observed in clinic, and when I called her at home the next day she said she felt better although not completely well.
This spontaneous report as received from a medical assistant refers to a patient of unknown age and gender. There was no information about the patient's concurrent conditions, concomitant therapies or medical history provided. On 02-NOV-2017, the patient was vaccinated with an improperly stored dose of VARIVAX lot # N001527, expiration date 13-JAN-2019 (dose, vaccination site and route of administration were not reported) which was reconstituted with properly stored sterile diluent (lot # and expiration date were not reported) for prophylaxis. No adverse effect were reported. Administered dose of vaccine underwent a temperature excursion from 6 degrees Fahrenheit to 14 degrees Fahrenheit for 30 minutes. Digital data logger was involved. There were no previous temperature excursions reported. This is one of three reports received from the same reporter.; Sender's Comments: US-009507513-1711USA009218: US-009507513-1711USA005336:
Large red splotch/rash about an inch-2 down from injection site. Started small the day after injection, got larger the next day, then became itchy.
pt reported devel gen rash 1 day p/vax; seen by MD 1JUL96 dx eczematous dermatitis no topic dermatitis;rx lidex syrter